Haematologica EWOG-MDS website
HOME HELP FEEDBACK ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


Published online 11 September 2008
(Haematologica 2008, 10.3324/haematol.13044)
Copyright © 2008 by Ferrata Storti Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Berg et al. - Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Berg, T.
Right arrow Articles by Lübbert, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, T.
Right arrow Articles by Lübbert, M.

Brief Report

Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO

Tobias Berg1, Manfred Fliegauf2, Jan Burger3, Martin S. Staege4, Shaohua Liu5, Natalia Martinez6, Olaf Heidenreich7, Stefan Burdach8, Torsten Haferlach9, Milton H. Werner10, Michael Lübbert1

1 Div. Hematology/Oncology, University of Freiburg Medical Center, Freiburg, Germany
2 Dept. Pediatrics, University of Freiburg Medical Center, Freiburg, Germany
3 Dept. of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4 Div. Ped. Hematology/Oncology, Martin-Luther-University Halle, Halle, Germany
5 Laboratory of Molecular Biophysics, The Rockefeller University, New York, NY, USA
6 Institute of Cell Biology, Department of Molecular Biology, Eberhard Karls University Tuebingen, Tuebingen, Germany
7 Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
8 Pediatric Oncology Center and Department of Pediatrics, Munich University of Technology, Munich, Germany
9 MLL Munich Leukemia Laboratory, Munich, Germany
10 Celtaxsys, ATDC Biosciences Center, Atlanta, GA, USA

Correspondence: Michael Lübbert, MD PhD, Department of Medicine, Division Hematology/Oncology, University of Freiburg Medical Center, Hugstetter Str. 55, D-79106 Freiburg, Germany. E-mail:luebbert{at}mm11.ukl.uni-freiburg.de

ABSTRACT

An inducible model for conditional expression of AML1-ETO in myeloid U-937 cells was generated previously to determine cellular effects of AML1-ETO and to identify target genes. Induction of AML1-ETO expression in U-937 resulted in reduced cell growth, G1 arrest and apoptosis. Microarray analysis showed more genes up-regulated than down-regulated (180 vs. 69). Clustering of AML1-ETO-positive and -negative cell lines was possible based on these differentially expressed genes. p21/WAF/Cip1 (CDKN1A) was up-regulated 4.6-fold upon induction of AML1-ETO which was confirmed in additional experiments. Knock-down of AML1-ETO by siRNA could reduce p21/WAF/Cip1 expression in Kasumi-1 cells. mRNA expression analysis of p21/WAF/Cip1 in a large cohort of acute myeloid leukemia patients demonstrated a significantly higher expression in AML1-ETO-positive leukemia. The increased expression of p21/WAF/Cip1 in primary leukemic blasts suggests that elevated p21/WAF/Cip1 levels may contribute to specific features observed in AML1-ETO positive leukemia.

Key words: cell cycle, acute myeloid leukemia, chromosomal translocation.







HOME HELP FEEDBACK ARCHIVE SUBSCRIPTIONS
Copyright © 2008 by the Ferrata Storti Foundation.